Nykredit A S Takes $55.89 Million Position in Intuitive Surgical, Inc. $ISRG

Nykredit A S purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 140,548 shares of the medical equipment provider’s stock, valued at approximately $55,893,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. State Street Corp raised its holdings in Intuitive Surgical by 1.0% during the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after purchasing an additional 162,264 shares during the last quarter. Capital World Investors grew its holdings in Intuitive Surgical by 1.7% in the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after purchasing an additional 127,526 shares during the last quarter. Norges Bank acquired a new stake in Intuitive Surgical in the fourth quarter valued at $2,856,987,000. Invesco Ltd. increased its position in shares of Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock valued at $2,338,350,000 after buying an additional 611,268 shares in the last quarter. Finally, Bank of America Corp DE increased its position in shares of Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after buying an additional 116,292 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Gary S. Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the sale, the director directly owned 1,245,679 shares in the company, valued at approximately $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of Intuitive Surgical stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the director owned 251 shares in the company, valued at approximately $95,129. This trade represents a 61.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 11,658 shares of company stock valued at $4,649,835. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $371.88 on Thursday. The firm has a 50 day simple moving average of $382.80 and a 200-day simple moving average of $429.86. The firm has a market cap of $131.38 billion, a PE ratio of 42.60, a P/E/G ratio of 2.79 and a beta of 1.47. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the firm posted $1.81 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on ISRG. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, August 21st. Stifel Nicolaus dropped their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Evercore set a $430.00 price target on shares of Intuitive Surgical in a report on Monday, July 6th. Finally, Bank of America lowered their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a research report on Friday, June 12th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $508.68.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.